Boucraut J, Hawley S, Robertson K, Bernard D, Loke Y W, Le Bouteiller P
Laboratoire d'Immunologie, Faculté de Médecine de la Timone, Marseille, France.
J Immunol. 1993 May 1;150(9):3882-94.
In order to investigate the possible molecular regulatory mechanisms that repress classical HLA class I and stimulate nonclassical HLA-G and E-class I gene transcription in human trophoblast cells, we searched for the nuclear expression of the enhancer A DNA-binding proteins of the KBF1/NF-KB/rel family. Using both purified extravillous cytotrophoblast and villous syncytiotrophoblast from first trimester human placenta, it appeared that members of this family were present in the cytotrophoblast and absent in the syncytiotrophoblast. First, using the double stranded enhancer A DNA nucleotidic sequence that contains the palindromic KB site, known to be the binding site of the p50 subunits of KBF1-NF-KB and c-rel factors, we demonstrated, by band-shift assay, that binding activity, inhibited by addition of anti-p50 polyclonal serum, was present in cytotrophoblast as well as control maternal decidual cells, embryonic fibroblasts, and the trophoblast-derived JAR cell line. In contrast, this DNA-protein complex was undetectable in syncytiotrophoblast nuclear extracts. The specificity of this protein-DNA complex was further demonstrated by its disappearance upon competition with an excess of cold homologous nucleotidic competitor. Other nucleoprotein complexes were also detected in all nuclear extracts, including syncytiotrophoblast, that were competed out by an excess of cold enhancer A competitor DNA but were not affected by the addition of anti-p50 or anti-NF-KB sera, suggesting the presence of additional enhancer A-binding factors different from the KBF1/NF-KB/rel family. Second, using a Western immunoblot analysis, a doublet around 85 kDa was specifically stained by the same anti-p50 serum in cytotrophoblast, maternal decidual cells, embryonic fibroblasts, and the JAR nuclear extracts whereas no signal was obtained in syncytiotrophoblast. Finally, immunofluorescence cell staining using the same anti-p50 serum showed a positive staining in both cytoplasm and nucleus of cytotrophoblast and its absence in syncytiotrophoblast. We hypothesize that this enhancer A DNA-binding factor might represent the c-rel trans-acting factor, related to p50/KBF1/NF-KB proteins, and we discuss its possible relevance to the HLA class I transcription in human tissues.
为了研究在人滋养层细胞中抑制经典HLA I类分子并刺激非经典HLA - G和E - I类基因转录的可能分子调控机制,我们寻找了KBF1/NF - KB/rel家族增强子A DNA结合蛋白的核表达情况。利用来自孕早期人胎盘的纯化的绒毛外细胞滋养层细胞和绒毛合体滋养层细胞,结果显示该家族成员存在于细胞滋养层细胞中,而在合体滋养层细胞中不存在。首先,使用包含回文KB位点的双链增强子A DNA核苷酸序列(已知该位点是KBF1 - NF - KB和c - rel因子的p50亚基的结合位点),我们通过凝胶迁移试验证明,在细胞滋养层细胞以及对照的母体蜕膜细胞、胚胎成纤维细胞和滋养层来源的JAR细胞系中,存在受抗p50多克隆血清抑制的结合活性。相比之下,在合体滋养层细胞核提取物中未检测到这种DNA - 蛋白质复合物。通过与过量的冷同源核苷酸竞争者竞争后该复合物消失,进一步证明了这种蛋白质 - DNA复合物的特异性。在所有细胞核提取物(包括合体滋养层细胞核提取物)中还检测到其他核蛋白复合物,它们被过量的冷增强子A竞争者DNA竞争掉,但不受抗p50或抗NF - KB血清添加的影响,这表明存在不同于KBF1/NF - KB/rel家族的其他增强子A结合因子。其次,使用蛋白质免疫印迹分析,在细胞滋养层细胞、母体蜕膜细胞、胚胎成纤维细胞和JAR细胞核提取物中,约85 kDa的双峰被同一种抗p50血清特异性染色,而在合体滋养层细胞中未获得信号。最后,使用同一种抗p50血清进行免疫荧光细胞染色显示,细胞滋养层细胞的细胞质和细胞核均呈阳性染色,而合体滋养层细胞中无染色。我们推测这种增强子A DNA结合因子可能代表与p50/KBF1/NF - KB蛋白相关的c - rel反式作用因子,并讨论了其与人组织中HLA I类转录的可能相关性。